Mario Balsa, Medical Oncology Resident at ICO, shared a post on X:
“Non-metastatic gastroesophageal adenocarcinoma – shifting landscape at ESMOGI25
– FLOT > CROSS for OS
– ↓ distant relapses with FLOT
– Peri-op IO rising: MIGHTY MATTERHORN!
– RT and adjuvant IO have lost ground
Climbing towards a new SoC — the Matterhorn is in sight!”
Read ESMO GI 2025 Highlights on OncoDaily.
